Vaxart Inc
F:NB11
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vaxart Inc
F:NB11
|
US |
|
C
|
CACI International Inc
F:CA8A
|
US |
|
C
|
Carlisle Companies Inc
XBER:CLE
|
US |
|
Lemonade Inc
F:LE0
|
US |
|
Vinci SA
PAR:DG
|
FR |
|
Northwest Bancshares Inc
NASDAQ:NWBI
|
US |
|
H
|
Halliburton Co
XMUN:HAL
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NB11's stock price target?
Not Available
NB11 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Vaxart Inc?
Projected CAGR
-9%
Over the last 7 years, the compound annual growth rate for Revenue has been 78%. The projected CAGR for the next 7 years is -9%.
What is the Operating Income forecast for Vaxart Inc?
Projected CAGR
-5%
The compound annual growth rate for Operating Income over the next 7 years is -5%.